UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.129

Sortiert nach

Patterns of Disease Progression after Carboplatin/Etoposide + Atezolizumab in Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)

International journal of radiation oncology, biology, physics, 2020-12, Vol.108 (5), p.1398-1398

2020

Volltextzugriff (PDF)

Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with COVID-19-Related Pneumonia

International journal of radiation oncology, biology, physics, 2020-12, Vol.108 (5), p.1401-1401

2020

Volltextzugriff (PDF)

National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1–3, 2000

JNCI : Journal of the National Cancer Institute, 2001-07, Vol.93 (13), p.979-989

2001

Volltextzugriff (PDF)

Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

JNCI : Journal of the National Cancer Institute, 2011-10, Vol.103 (19), p.1452-1460

2011

Volltextzugriff (PDF)

DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus

Cancer research (Chicago, Ill.), 2000-03, Vol.60 (5), p.1245-1253

2000

Volltextzugriff (PDF)

Early toxicity predicts long-term survival in high-grade glioma

British journal of cancer, 2011-04, Vol.104 (9), p.1365-1371

2011

Volltextzugriff (PDF)

Radiation Therapy Oncology Group (RTOG) 88–08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 1995-02, Vol.87 (3), p.198-205

1995

Volltextzugriff (PDF)

Spectrophotometer and ultrasound evaluation of late toxicity following breast-cancer radiotherapy

Medical physics (Lancaster), 2011-10, Vol.38 (10), p.5747-5755

2011

Volltextzugriff (PDF)

Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials

JNCI : Journal of the National Cancer Institute, 1993-05, Vol.85 (9), p.704-710

1993

Volltextzugriff (PDF)

Validation and Predictive Power of Radiation Therapy Oncology Group (RTOG) Recursive Partitioning Analysis Classes for Malignant Glioma Patients: A Report Using RTOG 90-06

International journal of radiation oncology, biology, physics, 1998, Vol.40 (1), p.51-55

1998

Volltextzugriff (PDF)

Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution

International journal of radiation oncology, biology, physics, 2001-08, Vol.50 (5), p.1265-1278

2001

Volltextzugriff (PDF)

Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx

Journal of clinical oncology, 1995-08, Vol.13 (8), p.2077-2083

1995

Volltextzugriff (PDF)

Procarbazine, Lomustine, and Vincristine (PCV) Chemotherapy for Anaplastic Astrocytoma: A Retrospective Review of Radiation Therapy Oncology Group Protocols Comparing Survival With Carmustine or PCV Adjuvant Chemotherapy

Journal of clinical oncology, 1999-11, Vol.17 (11), p.3389-3395

1999

Volltextzugriff (PDF)

A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma

International journal of radiation oncology, biology, physics, 1999-01, Vol.43 (2), p.293-298

1999

Volltextzugriff (PDF)

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06

Journal of clinical oncology, 1996-04, Vol.14 (4), p.1055-1064

1996

Volltextzugriff (PDF)

Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000?

Cancer, 1997-06, Vol.79 (12), p.2409-2413

1997

Volltextzugriff (PDF)

Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosis

Cell death and differentiation, 2014-07, Vol.21 (7), p.1160-1169

2014

Volltextzugriff (PDF)

Single-Arm, Open-Label Phase II Study of Intravenously Administered Tirapazamine and Radiation Therapy for Glioblastoma Multiforme

Journal of clinical oncology, 2000-03, Vol.18 (6), p.1254-1259

2000

Volltextzugriff (PDF)

Phase I Study of Topotecan Plus Cranial Radiation for Glioblastoma Multiforme: Results of Radiation Therapy Oncology Group Trial 9507

Journal of clinical oncology, 2001-02, Vol.19 (4), p.1111-1117

2001

Volltextzugriff (PDF)

Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive radiation therapy oncology group (RTOG) clinical trials

International journal of radiation oncology, biology, physics, 1993-05, Vol.26 (2), p.239-244

1993

Volltextzugriff (PDF)

Functional vision is improved in the majority of patients treated with external-beam radiotherapy for choroid metastases: a multivariate analysis of 188 patients

Journal of clinical oncology, 1997-03, Vol.15 (3), p.1244-1251

1997

Volltextzugriff (PDF)

Postoperative complications after combined neoadjuvant treatment of lung cancer

The Annals of thoracic surgery, 1993-04, Vol.55 (4), p.986-989

1993

Volltextzugriff (PDF)

Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83‐02

Cancer, 1996-04, Vol.77 (8), p.1535-1543

1996

Volltextzugriff (PDF)

A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404

International journal of radiation oncology, biology, physics, 1999-12, Vol.45 (5), p.1109-1115

1999

Volltextzugriff (PDF)

Immediate side effects of stereotactic radiotherapy and radiosurgery

International journal of radiation oncology, biology, physics, 1999-01, Vol.43 (2), p.299-304

1999

Volltextzugriff (PDF)

1 – 25 von 2.129

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.925)
Mit Volltextzugriff
(1.886)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Patterns of Disease Progression after Carboplatin/Etoposide + Atezolizumab in Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)

Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with COVID-19-Related Pneumonia

National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1–3, 2000

Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus

Early toxicity predicts long-term survival in high-grade glioma

Radiation Therapy Oncology Group (RTOG) 88–08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer

Spectrophotometer and ultrasound evaluation of late toxicity following breast-cancer radiotherapy

Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials

Validation and Predictive Power of Radiation Therapy Oncology Group (RTOG) Recursive Partitioning Analysis Classes for Malignant Glioma Patients: A Report Using RTOG 90-06

Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution

Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx

Procarbazine, Lomustine, and Vincristine (PCV) Chemotherapy for Anaplastic Astrocytoma: A Retrospective Review of Radiation Therapy Oncology Group Protocols Comparing Survival With Carmustine or PCV Adjuvant Chemotherapy

A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06

Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000?

Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosis

Single-Arm, Open-Label Phase II Study of Intravenously Administered Tirapazamine and Radiation Therapy for Glioblastoma Multiforme

Phase I Study of Topotecan Plus Cranial Radiation for Glioblastoma Multiforme: Results of Radiation Therapy Oncology Group Trial 9507

Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive radiation therapy oncology group (RTOG) clinical trials

Functional vision is improved in the majority of patients treated with external-beam radiotherapy for choroid metastases: a multivariate analysis of 188 patients

Postoperative complications after combined neoadjuvant treatment of lung cancer

Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83‐02

A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404

Immediate side effects of stereotactic radiotherapy and radiosurgery

Suchergebnisse filtern